Gold prices steady with focus on Ukraine-Russia, Jackson Hole
On April 29, 2025, Jennifer L. Davis, CEO of Health Care at Procter & Gamble Co. (NYSE:PG), sold 1,000 shares of the company’s common stock. The shares were sold at a weighted average price of $161.384, amounting to a total of $161,384. Following this transaction, Davis holds 51,964.9178 shares of Procter & Gamble directly.
Additionally, Davis has 14,838.4112 shares indirectly owned through a retirement plan trustee. The sale does not include any recent acquisitions of restricted stock units, which are part of her compensation package and are set to convert into common stock upon retirement.
In other recent news, Procter & Gamble (P&G) reported its fiscal Q3 2025 earnings, revealing an earnings per share (EPS) of $1.54, slightly below the forecast of $1.55. The company’s revenue was $19.78 billion, falling short of the expected $20.36 billion. Despite these results, P&G managed a 1% increase in organic sales and returned $3.8 billion to shareholders through dividends and share buybacks. The company also experienced a 90 basis point improvement in its core operating margin, indicating enhanced operational efficiency. Looking ahead, P&G anticipates fiscal 2025 organic sales growth of approximately 2% and core EPS growth of 2-4%.
In other developments, RBC Capital Markets upgraded Procter & Gamble’s stock rating to Outperform from Sector Perform, raising the price target to $177 from $164. This upgrade reflects confidence in P&G’s ability to navigate current market challenges, such as a global economic slowdown and inventory destocking. RBC Capital Markets highlighted P&G’s strengths in innovation, supply chain flexibility, and revenue growth management. These capabilities are considered vital for addressing the complexities of the current business environment. The endorsement from RBC Capital Markets suggests a positive outlook for P&G’s future performance, which may influence market sentiment toward the company’s stock.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.